<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Elomatic</provider_name><provider_url>https://www.elomatic.com</provider_url><author_name>Matti Vehni&#xE4;inen</author_name><author_url>https://www.elomatic.com/author/mattiadmin/</author_url><title>Elomatic responsible for process design of Biovian&#x2019;s new biopharmaceutical plant &#x2013; new opportunities for development of viruses</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="v3SvYzLRMk"&gt;&lt;a href="https://www.elomatic.com/news/elomatic-responsible-for-process-design-of-biovians-new-biopharmaceutical-plant-new-opportunities-for-development-of-viruses/"&gt;Elomatic responsible for process design of Biovian&#x2019;s new biopharmaceutical plant &#x2013; new opportunities for development of viruses&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.elomatic.com/news/elomatic-responsible-for-process-design-of-biovians-new-biopharmaceutical-plant-new-opportunities-for-development-of-viruses/embed/#?secret=v3SvYzLRMk" width="600" height="338" title="&#x201C;Elomatic responsible for process design of Biovian&#x2019;s new biopharmaceutical plant &#x2013; new opportunities for development of viruses&#x201D; &#x2014; Elomatic" data-secret="v3SvYzLRMk" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.elomatic.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://www.elomatic.com/wp-content/uploads/2023/11/Biovian-Viral-Vector-T9_www.jpg</thumbnail_url><thumbnail_width>1094</thumbnail_width><thumbnail_height>608</thumbnail_height><description>Biovian Oy, which develops and manufactures biopharmaceuticals, is building a new plant in Turku, Finland, and has selected engineering and consulting company Elomatic to carry out the basic process design for the project. The plant, which will operate on the model of a multipurpose factory, opens new opportunities for the development of virus innovations in Finland.</description></oembed>
